Reaction
Cystic Fibrosis Lung reporting signals
As of the last recalculation, Cystic Fibrosis Lung appears in 129 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is LUMACAFTOR AND IVACAFTOR (PRR 554.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lumacaftor And Ivacaftor | 24 | 554.9 | 556.5 |
| Dornase Alfa | 36 | 410.5 | 411.3 |
| Tobramycin | 33 | 297.2 | 297.6 |
| Tobramycin Solution | 12 | 177.6 | 177.8 |
| Tobramycin Sulfate | 12 | 172.3 | 172.5 |
| Pancrelipase | 31 | 170.3 | 170.4 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 9 | 125.1 | 125.2 |
| Ivacaftor | 3 | 62.4 | 62.4 |